Nureca Limited

NSEI:NURECA Stock Report

Market Cap: ₹2.8b

Nureca Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Nureca.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth22.5%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Nureca Limited (NSE:NURECA) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

Sep 06
Nureca Limited (NSE:NURECA) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

We Think Nureca Limited's (NSE:NURECA) CEO Compensation Package Needs To Be Put Under A Microscope

Jul 12
We Think Nureca Limited's (NSE:NURECA) CEO Compensation Package Needs To Be Put Under A Microscope

Nureca Limited (NSE:NURECA) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Mar 29
Nureca Limited (NSE:NURECA) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Nureca Limited's (NSE:NURECA) Shares Not Telling The Full Story

Jun 19
Nureca Limited's (NSE:NURECA) Shares Not Telling The Full Story

Robust Earnings May Not Tell The Whole Story For Nureca (NSE:NURECA)

Jun 23
Robust Earnings May Not Tell The Whole Story For Nureca (NSE:NURECA)

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nureca has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NSEI:NURECA - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2024908-283864N/A
6/30/20249106N/AN/AN/A
3/31/2024919-18-38-27N/A
12/31/20239628N/AN/AN/A
9/30/20231,01610-123-121N/A
6/30/20231,070-48N/AN/AN/A
3/31/20231,113-8298102N/A
12/31/20221,311-81N/AN/AN/A
9/30/20221,514-37-61-18N/A
6/30/20221,61646N/AN/AN/A
3/31/20222,555450-4614N/A
12/31/20212,602515N/AN/AN/A
9/30/20212,577518-130-104N/A
6/30/20213,027731N/AN/AN/A
3/31/20212,135464341349N/A
3/31/202099464-83-79N/A
3/31/20196196223N/A
3/31/201820131N/A1N/A
3/31/201700N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if NURECA's forecast earnings growth is above the savings rate (6.7%).

Earnings vs Market: Insufficient data to determine if NURECA's earnings are forecast to grow faster than the Indian market

High Growth Earnings: Insufficient data to determine if NURECA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if NURECA's revenue is forecast to grow faster than the Indian market.

High Growth Revenue: Insufficient data to determine if NURECA's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if NURECA's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y